Central Medical Supplies Ltd (CMS), the sole UK distributor for NeoMedLight’s innovative BiliCocoon® phototherapy system for newborn babies with jaundice, has supplied seventy of the systems to the East and West Midlands Neonatal Operational Delivery Networks.
Both the East and West Midlands Neonatal Operational Delivery Networks have received funding from NHS England Improvement (NHSEI), to set up community-based phototherapy services. The BiliCocoon® systems will be used to deliver safe, controlled phototherapy, to reduce the concentration of bilirubin in a baby’s blood.
Unlike traditional phototherapy treatment, where the infant is separated from mum for long periods, the BiliCocoon® system means there can be physical contact while a baby is undergoing essential light treatment. This benefits both a baby and its parents enormously. The BiliCocoon® system features a lightweight, portable light box connected to LED light pads that wrap around the infant.
Lynsey Clarke, Acting Lead Nurse at the West Midlands Neonatal Operational Delivery Network, says: “Phototherapy can be very traumatic so being able to carry out the treatment at home rather than a baby having to go back into hospital will be less stressful for everyone involved. The BiliCocoon® system is great, as it provides all the benefits of phototherapy treatment while giving mum and dad close contact so they can comfort their child. The system also enables nursing staff to have easy access to the baby. We’re looking forward to providing a community-based phototherapy service across the Midlands, the benefits of which will be enormous.”
For more information on the BiliCocoon® phototherapy system, contact Tracey Pavier-Grant, Medical Sales Director at Central Medical Supplies, on 01538 392 596, email email@example.com or visit www.centralmedical.co.uk